Initial Experience of the Levodopa–Entacapone–Carbidopa Intestinal Gel in Clinical Practice

Patients in fluctuating stages of Parkinson’s disease (PD) require device-aided treatments. Continuous infusion of levodopa–carbidopa intestinal gel (LCIG) is a well-proven option in clinical practice. We now report the first clinical experience of levodopa–entacapone–carbidopa intestinal gel (LECIG...

Descripción completa

Detalles Bibliográficos
Autores principales: Öthman, Mezin, Widman, Erik, Nygren, Ingela, Nyholm, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067183/
https://www.ncbi.nlm.nih.gov/pubmed/33807308
http://dx.doi.org/10.3390/jpm11040254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067183/
https://www.ncbi.nlm.nih.gov/pubmed/33807308
http://dx.doi.org/10.3390/jpm11040254

Ejemplares similares